SLC6A3 and Parkinson disease: For example, Liss and colleagues were able to distinguish midbrain dopamine neuron subpopulations on the basis of tyrosine hydroxylase (TH), vesicular monoamine transporter type 2 (Vmat2), and dopamine transporter (DAT) transcript expression ratios [2] and, in a separate study, demonstrated increased α-synuclein transcript levels in SN dopamine neurons from PD brains [6].